在新生儿阿片类药物戒断综合征的婴儿中调节肠道TLR4表达
Rebecca C Barnett1, Angela N Lewis2, Qingqing Gong3
1Department of Pediatrics, Marshall University, Joan C. Edwards School of Medicine, Huntington, WV, USA.
概括
新生儿阿片类药物戒断综合征 (NOWS) 没有显示像TLR4.4这样的肠道炎症标志物的增加. 这表明NOWS可能不会直接导致与新生儿死性肠球炎相关的炎症增加.
科学领域:
- 新生儿研究新生儿研究
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
背景情况:
- 新生儿阿片类戒断综合征 (NOWS) 与新生儿死性肠球炎 (NEC) 有关.
- 潜在的机制,特别是肠道炎症,需要进一步研究.
研究的目的:
- 为了调查NOWS的婴儿是否表现出基线肠道炎症的增加.
- 评估便基因表达TLR4和HMGB1作为炎症标志物.
主要方法:
- 从暴露于阿片类药物 (n=9) 和未暴露 (n=8) 的新生儿收集潜在的便样本.
- 对TLR4和HMGB1.1的便基因表达进行实时PCR分析.
主要成果:
- 与暴露于阿片类药物的新生儿相比,未暴露的新生儿在1-3天 (P < 0.0001) 和4-9天 (P < 0.05) 的TLR4表达显著更高.
- 在两个时间点 (P > 0.05) 中,两组之间没有观察到HMGB1表达的显著差异.
结论:
- 研究结果表明,增加的肠道炎症可能不是NOWS婴儿NEC的主要驱动因素.
- 阿片类药物暴露和NOWS可能会通过与TLR4和HMGB1有关的途径以外的途径影响新生儿的肠道炎症环境.
更多相关视频
09:12Assessing Cellular Stress and Inflammation in Discrete Oxytocin-secreting Brain Nuclei in the Neonatal Rat Before and After First Colostrum Feeding
Published on: November 14, 2018
7.9K
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
5.3K
相关概念视频
Analgesia and Pain Management
625
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
625
Opioid Receptors: Overview
860
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
860
